Schedule 13G ownership disclosure

ATHIRA PHARMA INC

Common Stock, $0.0001 par value · CUSIP: 04746L104

Event date: 2025-12-18

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BML Investment Partners, L.P.

    Shares: 0 · Class: 0%

  • Leonard Braden Michael

    Shares: 0 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001373604-25-000127
Form type
SCHEDULE 13G/A
Filer
LeonaBio, Inc.
CIK
CIK 1620463
Filed
Dec 18, 2025
Reporting period
Dec 18, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub